Sarah Ann Anderson
Affiliations: | 2013 | Pharmacology and System Biology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Google:
"Sarah Anderson"Mean distance: 16.47 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentor| Yasmin Hurd | grad student | 2013 | Mount Sinai School of Medicine | |
| (Probing the Interface of Heroin Abuse and Negative Mood States: A Translational Role for Amygdala Opioid Neuropeptides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Egervari G, Jutras-Aswad D, Landry J, et al. (2016) A Functional 3'UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Koo JW, Mazei-Robison MS, LaPlant Q, et al. (2015) Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area. Nature Neuroscience. 18: 415-22 |
| Michaelides M, Anderson SA, Ananth M, et al. (2013) Whole-brain circuit dissection in free-moving animals reveals cell-specific mesocorticolimbic networks. The Journal of Clinical Investigation. 123: 5342-50 |
| Anderson SA, Michaelides M, Zarnegar P, et al. (2013) Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression. The Journal of Clinical Investigation. 123: 5334-41 |